Trials / Completed
CompletedNCT00544934
Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects
A Dose-ranging Study to Evaluate the Safety, Metabolism and Therapeutic Dosing of Three Multiple Dose Levels of GLY-230 in Healthy and Diabetic Subjects
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Glycadia · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A dose-ranging study evaluating safety, metabolism and therapeutic dosing of three multiple dose levels of GLY-230 in healthy and diabetic subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLY-230 | 125, 250 0r 375 mg bid for 14 days |
| OTHER | Placebo | No drug administered |
Timeline
- Start date
- 2007-02-01
- Completion
- 2007-10-01
- First posted
- 2007-10-16
- Last updated
- 2016-02-10
Source: ClinicalTrials.gov record NCT00544934. Inclusion in this directory is not an endorsement.